ArticleClinical journal of gastroenterology2025
Remarkable response to durvalumab and tremelimumab in a patient with hepatocellular carcinoma: a case report.
Yosuke Osawa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it